PositiveID Corporation (OTCQB: PSID) is an emerging growth company that develops biological detection and diagnostic systems for America's homeland defense and the global healthcare market. PositiveID specializes in microfluidic systems for the automated preparation and performance of biological assays in order to detect biological threats and outbreaks whether airborne, in a healthcare setting, or at the point of need.
Mar 20, 2017
Mar 14, 2017
PositiveID's E-N-G Mobile Systems' 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter